Polygenic scores for cardiovascular risk factors improve estimation of clinical outcomes in CCB treatment compared to pharmacogenetic variants alone. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41397-024-00333-2
PubMed Identifier: 38632276
Publication URI: http://europepmc.org/abstract/MED/38632276
Type: Journal Article/Review
Volume: 24
Parent Publication: The pharmacogenomics journal
Issue: 3
ISSN: 1470-269X